My nursing career has primarily been oncology-focused, first within the solid tumour setting and then most recently, in haemato-oncology and stem cell transplant. My clinical roles have been varied and include working as a Haematology Research Nurse, Sister of a Haemato-Oncology Ambulatory Care Unit, Stem Cell Transplant Clinical Nurse Specialist, and Apheresis Specialist Nurse. I have also worked in the USA within the stem cell transplant setting.
I have been working clinically at the Royal Marsden Hospital since 2008, and as a Lecturer Practitioner at The Royal Marsden School since 2016. I was a student here at the School several years ago where I completed my MSC in Advanced Practice in Cancer Care. My dissertation was a research study titled ‘Exploring the Lived Experience of Nurses caring for Allogeneic Haematopoeitic Stem Cell Transplant patients’. It is therefore great to now work at the School and teach students, hopefully enabling them to improve the experience and outcomes of their patients through the application of higher education.
I am particularly interested in novel innovations and therapies within haemato-oncology, including CAR-T cell and other immune and cellular therapies, and also new approaches to supportive care, and educating patients and carers.
Module Involvement
I have been involved with a variety of modules at the School, including Principles of Anti-Cancer Therapy and Critical Reflection in Clinical Practice, and currently lead on the Principles of Haemato-Oncology Care module, the Principles of Stem Cell Transplantation and Cellular Therapy, and the Enhancing Your Practice in Cancer Care.
I am also the Lead for Level 6 modules and the BSc Programme.
Committee Involvement
I was a member of the European Group for Blood and marrow Transplant and Cellular Therapy(EBMT) Scientific Committee for the EBMT Nurses Group from 2018 to 2021. In this role, I facilitated the planning and delivery of educational content for nurses at the annual international EBMT conference.
Abstracts accepted for Oral Presentations
2021: ‘Evaluating involving patient experiences in cancer nursing education’. International Conference of Cancer Nursing. Virtual.
2015: ‘Exploring the lived experience of nurses caring for allogeneic stem cell transplant patients. Congress of the European Group for Blood and Marrow Transplantation, Istanbul, Turkey.
2015: ‘Plerixafor: How to achieve the best patient outcome? The role of the Apheresis Nurse’. Congress of the European Group for Blood and Marrow Transplantation, Istanbul, Turkey.
2012: ‘Nursing aspects of Extracorporeal Photopheresis’, UK Nurses group, European Group for Blood and Marrow Transplantation, London, UK.
2011: ‘Thrombotic Thrombocytopenic Purpura: a medical emergency; a nursing challenge’, Congress of the European Group for Blood and Marrow Transplantation, Paris, France.
2011: Thrombotic Thrombocytopenic Purpura: a medical emergency; a nursing challenge’, UK Nurses group, European Group for Blood and Marrow Transplantation, Manchester, UK.
2010: ‘Hope for poor mobilisers? Our experience with Plerixafor’ A tale of two units: stem cell collection in the UK and the USA; a comparison’, Congress of the European Group for Blood and Marrow Transplantation, Vienna, Austria.
2010: ‘Stem cell collection: a tale of 3 units. A UK/USA/Slovak comparison’ Conference of Haematology and Transfusion, Kosice, Slovak Republic.
2010: ‘Hope for poor mobilisers? Our experience with Plerixafor’, UK Nurses group, European Group for Blood and Marrow Transplantation, York, UK.
Abstracts accepted for Poster Presentations:
2021: A tale of two collections: CAR-T versus PBSC. Our single centre experience. Congress of the European Group for Blood and Marrow Transplantation, Virtual.
2021: ‘The creation of a new oncology specialist nursing role for the delivery of cellular therapies. International Conference of Cancer Nursing. Virtual.
2019: ‘Preparing the Apheresis Service for the introduction and delivery of novel cellular therapy: Challenges and Solutions. Congress of the European Group for Blood and Marrow Transplantation, Frankfurt, Germany.
2016: ‘How much is really enough? Stem cell target doses and the implications for the Apheresis service’. Congress of the European Group for Blood and Marrow Transplantation, Valencia, Spain.
2013: ‘How do collection?’. Congress of the European Group for Blood and Marrow Transplantation, London, UK.
2011: ‘Venesection as an intervention for elevated serum ferritin levels post-allogeneic transplant: management in the ambulatory care unit’, Congress of the European Group for Blood and Marrow Transplantation, Paris, France.
Publications:
2018: Contributing author in the Royal Marsden Manual for Cancer Nursing Procedures (2018). Lister, S. and Dougherty, L (eds). Chapter 2, Haematological Procedures. Chichester: Wiley Blackwell.
2017: Journal of Oncology Pharmacy Practice, 23 (8), Supplement, page 56 administration in an ambulatory setting. Lister, S., Nabhani, S., Barton,S., Baker, J., Soni, V. The stability of Plerixafor (Mozobil) in pre-filled syringes for a patient.
Contact details
020 7808 2521